🇮🇳IN
Sign In
DR

DRREDDY

NSE

Dr Reddys Laboratories Ltd

₹1,229.50

-9.50(-0.77%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

DRREDDY financial summary

For Mar 2026, Dr Reddys Laboratories Ltd reported revenue of ₹20,533 crore, which fell 11.2% from the previous year. Net profit was ₹3,220 crore, which fell 39.8% year on year, on an operating margin of 19%. Earnings per share came in at ₹38.58. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹20,533 crore
Net profit₹3,220 crore
Operating margin19%
EPS₹38.58

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer